You are here

Prices & Quotes - UK Markets - Venture Life Group (VLG)

Risk Warning The value of investments can fall as well as rise and any income from them is not guaranteed and you may get back less than you invested. Past performance is not a guide to future performance.

Share Price:
Down 35.25p
Change Today:
-12.75p
Market Cap:
44.36m
Sector:
Health Care Equipment & Services

Venture Life joins Covid-19 mouthwash trial

By Josh White

Date: Monday 24 Aug 2020

LONDON (ShareCast) - (Sharecast News) - Self-care products company Venture Life announced its involvement in a UK-led clinical trial on Covid-19 patients on Monday, in partnership with Cardiff University.
The AIM-traded firm had announced its support for further research into the idea that using mouthwash could reduce the transmission of enveloped viruses such as Covid-19 on 15 May.

It said on Monday that the new independent, multi-centre clinical study, which was being led by Professor David Thomas at Cardiff, would investigate the possibility that using over-the-counter mouthwashes could help to reduce the viral load, and thus the transmission of Covid-19 in the mouth.

Venture Life said it was "delighted" to confirm that its mouthwash brand 'Dentyl' would be involved in the UK clinical trial.

It said a literature review of previous research led by Professor Valerie O'Donnell at Cardiff, and expert input from a group of virologists, microbiocide experts, lipid specialists and healthcare experts from the universities of Cardiff, Nottingham, Ottawa and Barcelona, published in May, suggested the possibility that certain mouthwashes could be used to help reduce transmission of enveloped viruses such as SARS-CoV2, but that more research was needed to test the idea.

The review concluded that cetylpyridinium chloride (CPC) could be effective in that respect.

Venture Life said its Dentyl mouthwash, which is currently sold in the UK and 11 other countries, contains CPC as its main active ingredient.

The clinical study entitled 'the measurement of mouthwash antiviral activity against Covid-19' would be starting this month, and was expected to last for 12 weeks.

It would be a multi-centre study, and would recruit patients currently in hospital with Covid-19, beginning at Cardiff Hospital.

"We are the only mouthwash manufacturer to be involved in the Cardiff University clinical study on Covid-19 patients; we are delighted to support this independent study to further explore the initial findings that CPC may reduce the viral load and therefore the possible transmission of Covid-19," said chief executive officer Jerry Randall.

"Our Dentyl mouthwash, which uses CPC as its main antibacterial agent, has been developed by dentists and is recommended by dentists to reduce plaque in the mouth, and is very effective at this.

"We are excited at the prospect that this long standing, well known mouthwash product could help in the fight against Covid-19."

At 1512 BST, shares in Venture Life Group were up 7.51% at 93p.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

VLG Market Data

Currency UK Pounds
Price 35.25p
Change Today -12.75p
52 Week High 103.00p
52 Week Low 33.31p
Volume 3,134,677
Shares Issued 125.83m
Market Cap 44.36m
Beta 0.24

Performance Indicators

Compare performance with the sector and the market.

Key
Vs Market
Vs Sector
Value
market
  1. full market star
  2. full market star
  3. full market star
  4. half market star
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. full sector star
  5. empty sector
Price Trend
market
  1. full market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. half sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
Income
market
  1. full market star
  2. half market star
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. half sector star
  3. empty sector
  4. empty sector
  5. empty sector
Growth
market
  1. full market star
  2. full market star
  3. full market star
  4. full market star
  5. half market star
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. full sector star
  5. full sector star
Price Chg 6m
market
  1. empty market
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. empty sector
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
P/E
market
  1. full market star
  2. full market star
  3. full market star
  4. full market star
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. full sector star
  5. empty sector
PEG
market
  1. half market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. half sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
Dividend Yield
Not Available
EPS Growth
market
  1. full market star
  2. full market star
  3. full market star
  4. full market star
  5. half market star
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. full sector star
  5. half sector star
Operating Margin
market
  1. full market star
  2. full market star
  3. full market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. half sector star
  5. empty sector

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

VLG Dividends

  Latest Previous
  Final Interim
Ex-Div 24-May-18 n/a
Paid 22-Jun-18 n/a
Amount 0.040p 0.000p

Trades for 01-Dec-2021

Time Volume / Share Price
15:28 13,989 @ 35.30p
15:20 13,989 @ 35.18p
15:20 12,000 @ 35.10p
15:19 4,293 @ 35.10p
15:18 185 @ 34.50p

VLG Key Personnel

CEO Jerry Randall